Loading stock data…
$4.79-0.11 (-2.24%)
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States.
Champions Oncology, Inc. in the Healthcare sector is trading at $4.79 with a market capitalization of $66M. The stock is currently near its 52-week low of $4.59, remaining 18.4% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $13.84M↓ | $16.56M↑ | $15.04M↑ | $13.99M |
| Gross Profit | — | $7.03M↓ | $7.72M↓ | $7.77M↑ | $6.00M |
| Operating Income | — | -$521,000↓ | -$187,000↓ | $185,000↑ | -$507,000 |
| Net Income | — | -$667,000↓ | -$279,000↓ | $299,000↑ | -$466,000 |
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immun...